Sam Altman is advancing non-invasive brain technology with Merge Labs, partnering with Mikhail Shapiro to innovate ultrasound applications for brain-computer interfaces, challenging Neuralink.
- OpenAI CEO Sam Altman is collaborating with biomolecular engineer Mikhail Shapiro at his startup company, Merge Labs, to develop groundbreaking ultrasound technology for the human brain.
- The focus of Merge Labs is on creating a non-invasive brain-computer interface that utilizes sound, positioning it as a competitor to Elon Musks Neuralink in the brain-tech sector.
- This strategic partnership comes after reports that Altman was interested in backing brain implant technologies, indicating a significant shift towards innovative approaches in brain research.
Why It Matters
The development of non-invasive technologies by Sam Altman through Merge Labs could revolutionize how we interact with the human brain, potentially making brain-computer interfaces more accessible and effective, thus influencing future technological advancements and ethical discussions in neuroscience.